News

BioM's articles and press releases about the Bavarian biotechnology sector


Startups can now apply for EIT Health Accelerator 2017

We are pleased to an­nounce that star­tups can now apply for EIT Health Ac­cel­er­at­or 2017 pro­grams until 31 March 2017. Start-ups can…

Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance

Foun­ded in Fre­is­ing (near Mu­nich), co-loc­ated in Bo­ston (USA), NASDAQ-lis­ted Pier­is joins forces in im­muno-on­co­logy drug…

Recent developments in personalized medicine

On Novem­ber 29 and 30, 230 ex­perts from all over Europe par­ti­cip­ated in the 6th Mu­nich Bio­mark­er Con­fer­ence in Mu­nich. The…

Strong immuno start in Munich: iOmx hits the ground running

Im­muno-on­co­logy star­tup iOmx Thera­peut­ics has raised 40 mil­lion Euro in its first round of fin­an­cing.

Medigene (Munich) launches a billion-dollar collaboration with bluebird bio

"We are de­lighted to col­lab­or­ate with blue­bird bio, a lead­er in the field of cell and gene ther­apy, in­clud­ing can­cer…

Rigontec: 15 million euros for a new immunotherapy RNA-technology

The Mu­nich-based firm also starts to gain a foothold in the Amer­ic­an mar­ket by set­ting up a new com­pany in the US (Bo­ston).

Horst Domdey in Nature Outlook: Research Commercialization

Mu­nich Bi­otech Cluster and les­sons learned in 20 years of sup­port for en­tre­pren­eur­ship in bio­pharma.

Opening of BioSysM on Campus Martinsried-Großhadern

On April 19th, the Center for Molecu­lar Biosys­tems (BioSysM) of the Lud­wig-Max­imili­ans-Universität (LMU) cel­eb­rated its of­fi­cial…

Kick-off of the new stem cell center CARE in Munich

On April 13th, the planned stem cell re­search cen­ter CARE was presen­ted to politi­cians, sci­ent­ists and man­agers of pharma and…

Martinsried-based CRELUX acquired by WuXi AppTec from Shanghai

Today, WuXi App (Shang­hai) an­nounced the ac­quis­i­tion of CRELUX GmbH from Martin­sried near Mu­nich. With the ac­quis­i­tion, the…